Jun 26, 2025, 13:45
Dr Sthanu Subramanian: Tenecteplase VS Alteplase – TNK Targets the Fibrin in Blood Clots More Effectively
Dr. Sthanu Subramanian shared a post on X:
“Tenecteplase (TNK) vs. Alteplase (tPA):
TNK targets the fibrin in blood clots more effectively.
This means it is less likely to activate the body’s natural clotting system elsewhere, potentially reducing the risk of bleeding complications.”
Read also Dr Sthanu Subramanian Highlights EMS Protocols for Managing Atrial Fibrillation.
-
Aug 26, 2026, 18:38Maia Meier: Muhiba’s Story of Courage, Resilience and Hope With Type 3 VWD
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero
-
Aug 26, 2026, 18:24New Educational Content for the Bleeding Disorders Community – EAHAD
-
Aug 26, 2026, 18:14N. Mariana S. Vasquez: From Skin and Gut to Celiac Disease
-
Aug 26, 2026, 18:13Francesca Granata: What Happens When Patients Become Researchers and Researchers Become Advocates?
-
Aug 26, 2026, 18:11Maxima Mendez: Statins Are No Longer the Whole Story
-
Aug 26, 2026, 18:06Ashkan Shoamanesh: ANNEXa-I Analyses Inform Individualized Treatment in Intracranial Hemorrhage
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests